Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,070,000 | 6,597,000 | 5,213,000 | 3,488,000 | 1,834,000 |
| Depreciation Amortization | 446,000 | 1,662,000 | 1,274,000 | 832,000 | 412,000 |
| Income taxes - deferred | -47,000 | -74,000 | N/A | N/A | N/A |
| Accounts receivable | -371,000 | -516,000 | -636,000 | -585,000 | -152,000 |
| Other Working Capital | -451,000 | -198,000 | -627,000 | -1,016,000 | -311,000 |
| Other Operating Activity | 389,000 | 705,000 | 825,000 | 774,000 | 152,000 |
| Operating Cash Flow | $2,036,000 | $8,176,000 | $6,049,000 | $3,493,000 | $1,935,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -405,000 | -1,943,000 | -1,160,000 | -674,000 | -332,000 |
| Net Acquisitions | -258,000 | -478,000 | -466,000 | -466,000 | -28,000 |
| Purchase Of Investment | -1,634,000 | -6,923,000 | -4,423,000 | -3,126,000 | -1,689,000 |
| Sale Of Investment | 1,417,000 | 7,353,000 | 5,338,000 | 3,942,000 | 2,023,000 |
| Other Investing Activity | -17,000 | -206,000 | -129,000 | -213,000 | -58,000 |
| Investing Cash Flow | $-897,000 | $-2,197,000 | $-840,000 | $-537,000 | $-84,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 221,000 | 2,359,000 | 2,441,000 | 2,189,000 | 272,000 |
| Debt Issued | 2,000 | 22,000 | 20,000 | 20,000 | 17,000 |
| Debt Repayment | -20,000 | -245,000 | -221,000 | -16,000 | -12,000 |
| Common Stock Issued | 90,000 | 390,000 | 283,000 | 227,000 | 164,000 |
| Common Stock Repurchased | -339,000 | -6,538,000 | -6,181,000 | -5,255,000 | -1,899,000 |
| Dividend Paid | -609,000 | -2,381,000 | -1,772,000 | -1,163,000 | -549,000 |
| Other Financing Activity | -354,000 | -560,000 | -461,000 | -219,000 | -156,000 |
| Financing Cash Flow | $-1,009,000 | $-6,953,000 | $-5,891,000 | $-4,217,000 | $-2,163,000 |
| Exchange Rate Effect | 37,000 | 110,000 | 85,000 | 109,000 | -9,000 |
| Beginning Cash Position | 2,894,000 | 3,758,000 | 3,758,000 | 3,758,000 | 3,758,000 |
| End Cash Position | 3,061,000 | 2,894,000 | 3,161,000 | 2,606,000 | 3,437,000 |
| Net Cash Flow | $167,000 | $-864,000 | $-597,000 | $-1,152,000 | $-321,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,036,000 | 8,176,000 | 6,049,000 | 3,493,000 | 1,935,000 |
| Capital Expenditure | -408,000 | -2,099,000 | -1,299,000 | -802,000 | -350,000 |
| Free Cash Flow | 1,628,000 | 6,077,000 | 4,750,000 | 2,691,000 | 1,585,000 |